Erratum to: Comparison of Adjuvant Versus Salvage Radiotherapy Policies for Postprostatectomy Radiotherapy. (Comparison of adjuvant versus salvage radiotherapy policies for postprostatectomy radiotherapy (2004) 59(2) (329–340), (S0360301603023502) (10.1016/j.ijrobp.2003.11.038));Comparison of adjuvant versus salvage radiotherapy policies for postprostatectomy radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 2, 2004, Pages 329-340

  Hagan, Michael ^a   Zlotecki, Robert ^b   Medina, Camillo ^b   Tercilla, Oscar ^a   Rivera, Inoel ^b   Wajsman, Zev ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Adjuvant radiotherapy; Prostatectomy; Salvage radiotherapy

Indexed keywords

BIOCHEMISTRY; ONCOLOGY; PATIENT MONITORING; PATIENT TREATMENT; SALVAGING;

ADJUVANT; POSTPROSTATECTOMY;

RADIOTHERAPY;

ADJUVANT THERAPY; AGED; ANTIGEN SPECIFICITY; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RADIATION RESPONSE; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 2442598231     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2018.06.034     Document Type: Erratum

References (38)

1. Walsh P.C., Donker P.J. Impotence following radical prostatectomy Insight into etiology and prevention. J Urol. 128:1982;492-497
2. Lu-Yao G.L., McLerran D., Wasson J., et al. An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. JAMA. 269:1993;2633-2636
3. Frazier H.A., Robertson J.E., Humphrey P.A., et al. Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy? Urology. 149:1993;516-518
4. Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 281:1999;1591-1597
5. Stein A., deKernion J.B., Dorey F. Prostate specific antigen related to clinical status 1 to 14 years after radical retropubic prostatectomy. Br J Urol. 67:1991;626-631
6. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: Results at 10 years. J Urol 1994;152(5 Pt 2):1831-1836
7. Kattan M.W., Wheeler T.M., Scardino P.T. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol. 17:1999;1499-1507
8. Anscher M., Prosnitz L. Multivariate analysis of factors predicting local relapse after radical prostatectomy Possible indications for postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 21:1991;941-947
9. Cheng L., Darson M.F., Bergstralh E.J., et al. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer. 86:1999;1775-1782
10. Grossfeld G.D., Tigrani V.S., Nudell D., et al. Management of a positive surgical margin after radical prostatectomy Decision analysis. J Urol. 164:2000;93-99
11. Morris M., Dallow K., Zietman A., et al. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys. 38:1997;731-736
12. Partin A.W., Mangold L.A., Lamm D.M., et al. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology. 58:2001;843-848
13. Stamey T.A., McNeal J.E., Yemoto C.M., et al. Biological determinants of cancer progression in men with prostate cancer. JAMA. 281:1999;1395-1400
14. Babaian R.J., Troncoso P., Bhadkamkar V.A., et al. Analysis of clinicopathologic factors predicting outcome after radical prostatectomy. Cancer. 91:2001;1414-1422
15. Blute M.L., Bostwick D.G., Bergstralh E.K., et al. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Urology. 50:1997;733-739
16. Mai K.T., Moazin M., Morash C., et al. Transitional zone and anterior peripheral zone of the prostate A correlation of small-volume cancer in the biopsy cores and high PSA with positive anterior margins in radical prostatectomy specimens. Urol Int. 66:2001;191-196
17. Bauer J.J., Connelly R.R., Sesterhenn I.A., et al. Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer. J Urol. 159:1998;929-933
18. Kattan M.W., Eastham J.A., Stapleton M.F., et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst. 90:1998;766-771
19. Partin A.W., Piantadosi S., Marshall F.F. Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy. Urology. 45:1993;831
20. Tiguert R., Forman J.D., Hussain M., et al. Radiation therapy for a rising PSA level after radical prostatectomy. Semin Urol Oncol. 17:1999;141-147
21. Thompson I., Crawford E., Miller G., et al. Adjuvant radiotherapy following radical prostatectomy for pathologic stage C adenocarcinoma of the prostate Initial evaluation of toxicity. Proc Ann Meet Soc Clin Oncol. 11:1992;211-212
22. Catton C., Gospodarowicz M., Warde P., et al. Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. Radiother Oncol. 59:2001;51-60
23. Kaplan E.L., Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc. 53:1958;457-481
24. Cox D. Regression models and life tables. J R Stat Soc B. 34:1972;187-202
25. Obek C., Sadek S., Lai S., et al. Positive surgical margins with radical retropubic prostatectomy Anatomic site-specific pathologic analysis and impact on prognosis. Urology. 54:1999;682-688
26. Sehdev A.E., Pan C.C., Epstein J.I. Comparative analysis of sampling methods for grossing radical prostatectomy specimens performed for nonpalpable (stage T1c) prostatic adenocarcinoma. Hum Pathol. 32:2001;494-499
27. Hudson M., Catalona W. Effect of adjuvant radiation therapy on prostate specific antigen following radical prostatectomy. J Urol. 143:1990;1174-1177
28. Link P., Freiha F., Stamey T. Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. J Urol. 145:1991;532-534
29. Kaplan I., Bagshaw M. Serum prostate-specific antigen after post prostatectomy radiotherapy. Urology. 39:1992;401-406
30. McCarthy J., Catalona W., Hudson M. Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy Early versus delayed treatment. J Urol. 151:1994;1575-1578
31. Wu J., King S., Montana G., et al. The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. Int J Radiat Oncol Biol Phys. 32:1995;317-323
32. Forman J., Velasco J. Therapeutic radiation in patients with a rising post-prostatectomy PSA level. Oncology (Huntingt). 12:1998;33-39
33. Schild S., Buskirk S., Wong W., et al. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J Urol. 156:1996;1725-1729
34. Valicenti R., Gomella L., Ismail M., et al. Effect of higher radiation dose on biochemical control after radical prostatectomy for pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys. 42:1998;501-506
35. vander Kooy M.J., Pisansky T.M., Cha S.S., et al. Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy. Urology. 49:1997;65-70
36. Rogers R., Grossfeld G.D., Roach M. III, et al. Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy. J Urol. 160:1998;1748-1753
37. Anscher M.S., Clough R., Dodge R. Radiotherapy for a rising prostate-specific antigen after radical prostatectomy The first 10 years. Int J Radiat Oncol Biol Phys. 48:2000;369-375
38. Corn B.W., Winter K., Pilepich M.V. Radiation Therapy Oncology Group. Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Urology. 54:1999;495-502